ANDA 77218, held by Arco Pharms LLC. Potassium Iodide.
As of Nov 15, 2026, ANDA 77218 (Thyroshield), held by Arco Pharms LLC, was first approved by FDA on Jan 12, 2005, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 12, 2005 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Thyroshield65MG/ML ยท solution;oral | Potassium Iodide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
